Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
40.37
-0.46 (-1.13%)
Nov 6, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 12.85 billion as of November 6, 2026. It is the 6,672nd most valuable company in the world and the 1,244th biggest in China. Its market cap has decreased by 10.97% in one year.
Market Cap
12.85B
Enterprise Value
10.61B
Revenue
3.07B
Global Rank
Country Rank
#1,244 China
PE Ratio
13.11
ChartMarket Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 12.85B, an increase of 787.44%. That is a compound annual growth rate of 8.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 12.85B | -6.30% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Kangtai Biological Products | 14.30B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 14.12B |
| Harbin Pharmaceutical Group | 13.98B |
| Zhejiang Jiuzhou Pharmaceutical | 13.88B |
| Henan Lingrui Pharmaceutical | 13.54B |
| ApicHope Pharmaceutical Group | 13.36B |
| Porton Pharma Solutions | 12.99B |
| Fujian Cosunter Pharmaceutical | 12.72B |